Statistics

Total Visits

Views
Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro43

Select a period of time:

Number of views in the range

Views
Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro30

Views

Views
January 20251
February 20252
March 202515
April 20252
May 20255
June 20255
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore25
United States4
Spain1
 

Top cities views

Views
Council Bluffs1
Pasadena1